Published in Gesundheitswesen on February 01, 2003
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet (1999) 5.02
Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71
Interventions to reduce harm associated with adolescent substance use. Lancet (2007) 3.98
Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet (2001) 3.97
Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction (1999) 3.00
Characteristics of binge drinkers in Europe. Soc Sci Med (2004) 2.63
The heroin prescribing debate: integrating science and politics. Science (1999) 2.61
The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together. Drug Alcohol Depend (2010) 2.37
Pet birds as an independent risk factor for lung cancer: case-control study. BMJ (1992) 2.34
Social costs of untreated opioid dependence. J Urban Health (2000) 2.18
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health (1999) 1.99
An overview of illegal opioid use and health services utilization in Canada. Public Health (2006) 1.97
Clinical assessment compared with breathalyser readings in the emergency room: concordance of ICD-10 Y90 and Y91 codes. Emerg Med J (2005) 1.87
The case for a heroin substitution treatment trial in Canada. Can J Public Health (1998) 1.86
Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. J Nerv Ment Dis (1996) 1.70
The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada. CMAJ (2000) 1.68
Relation between average alcohol consumption and disease: an overview. Eur Addict Res (2001) 1.62
Privatizing alcohol sales and alcohol consumption: evidence and implications. Addiction (1999) 1.54
The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction (1998) 1.53
Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time. CMAJ (2000) 1.52
Moderate drinking and health. Implications of recent evidence. Can Fam Physician (1997) 1.50
Low-risk drinking guidelines: the scientific evidence. Can J Public Health (1999) 1.43
Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Can J Public Health (2001) 1.39
Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect (2010) 1.36
Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet (1999) 1.36
Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'? Public Health (1997) 1.17
Limitations of diagnostic paradigm: it doesn't explain "need". Arch Gen Psychiatry (1998) 1.13
High viable cell concentration fed-batch cultures of hybridoma cells through on-line nutrient feeding. Biotechnol Bioeng (1995) 1.13
Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Can J Public Health (1999) 1.02
Thrombin injection for treating a subclavian artery pseudoaneurysm. Surgery (2000) 0.97
Alteration of mammalian cell metabolism by dynamic nutrient feeding. Cytotechnology (1997) 0.95
Alcohol consumption and infectious diseases in South Africa. Lancet (2009) 0.94
Dimensions of alcohol-related social and health consequences in survey research. J Subst Abuse (2000) 0.94
The economic costs of alcohol abuse in Ontario. Pharmacol Res (1998) 0.93
Alcohol consumption and mortality. What do we know and where should we go? Addiction (2000) 0.93
Methodological approaches to conducting pooled cross-sectional time series analysis: the example of the association between all-cause mortality and per capita alcohol consumption for men in 15 European states. Eur Addict Res (2001) 0.92
Is frequency of drinking an indicator of problem drinking? A psychometric analysis of a modified version of the alcohol use disorders identification test in Switzerland. Drug Alcohol Depend (2001) 0.92
The interplay of drinking patterns and other determinants of health. Drug Alcohol Rev (1998) 0.91
Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health (2012) 0.89
Lifestyle and trends in worldwide breast cancer rates. Ann N Y Acad Sci (1990) 0.88
Patterns of alcohol consumption and acute myocardial infarction: a case-crossover analysis. Eur Addict Res (2009) 0.88
How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults. Eur Addict Res (2008) 0.87
Cost of addiction in Europe. Eur J Neurol (2005) 0.85
Does social integration confound the relation between alcohol consumption and mortality in the Multiple Risk Factor Intervention Trial (MRFIT)? J Stud Alcohol (1999) 0.85
Predictors of health risk behaviours among young adults: analysis of the National Population Health Survey. Can J Public Health (1999) 0.85
Alcohol and suicide in Switzerland--an aggregate-level analysis. Drug Alcohol Rev (1998) 0.84
Alcohol and all-cause mortality in Europe 1982-1990: a pooled cross-section time-series analysis. Addiction (1998) 0.84
Dimensions underlying legislator support for tobacco control policies. Tob Control (2003) 0.83
Incorporating the AUDIT into a general population telephone survey: a methodological experiment. Drug Alcohol Depend (2000) 0.82
The relationship between coffee consumption and serum cholesterol under consideration of smoking history. Eur J Epidemiol (1993) 0.81
Drinking patterns and traffic casualties in Switzerland: matching survey data and police records to design preventive action. Public Health (2005) 0.81
Guidelines on sensible drinking. Addiction (1996) 0.80
Young teenagers and access to alcohol in a Swiss canton: evidence from observational testing and from a telephone survey. Addiction (1995) 0.80
Blame and punishment for intoxicated aggression: when is the perpetrator culpable? Addiction (1998) 0.79
Implications of privatizing/deregulating alcohol retail sales: projections of alcohol consumption in Ontario. J Subst Abuse (1998) 0.78
Drinking patterns, risk taking and road accidents of young drivers: results of a Swiss case-control study. Soz Praventivmed (1994) 0.78
Re: "Alcohol intake assessment: the sober facts". Am J Epidemiol (2000) 0.78
Perception of traffic accident risk and decision to drive under light alcohol consumption--a double-blind experimental study. J Subst Abuse (2000) 0.77
Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). Eur Psychiatry (2011) 0.77
Alcohol-induced hypertension: an important healthcare target in Belgium. Acta Clin Belg (2015) 0.77
[Economic evaluation in a trial of medically controlled prescription of narcotics to dependent users (PROVE)]. Soz Praventivmed (1998) 0.77
Research and the alcohol industry. Addiction (2003) 0.77
[Evaluation of different breathing and contrast-protocols concerning quality and alignment in 18F-FDG PET/CT]. Rofo (2006) 0.77
Advancing educational scholarship through the End of Life Physician Education Resource Center (EPERC). J Palliat Med (1999) 0.76
[Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)]. Internist (Berl) (1999) 0.76
Sociodemographic factors and prevalence rates of mental illness in Germany and the United States. J Nerv Ment Dis (1997) 0.75
Alcohol and all-cause mortality. Int J Epidemiol (1996) 0.75
Can legislation prevent debauchery? Mother gin and public health in 18th-century England. Am J Public Health (2001) 0.75
Authorship, inclusion and hierarchy. Addiction (2001) 0.75
Re: light drinking has positive public health consequences. Ann Oncol (2013) 0.75
[Do we really need health economics in psychiatry? Why do we need health economics in psychiatry?]. Psychiatr Prax (2001) 0.75
Evaluation of community services. Acta Psychiatr Belg (1986) 0.75
[Can health be damaged by consuming cannabis? (author's transl)]. Schweiz Rundsch Med Prax (1979) 0.75
[Sociopsychiatric treatment combination in patients who are partly inpatients and genuine outpatients: definition and comparison (author's transl)]. Psychiatr Prax (1979) 0.75
[Willing to undergo hepatitis C treatment in a sample of injection drug users in Toronto, Canada]. Presse Med (2005) 0.75
[Comparative hospital tours: visiting the oasis of psychiatry]. Gesundheitswesen (2001) 0.75
[Medical ethics of heroin prescription by physicians]. Nervenarzt (2001) 0.75
[8 years experience with heroin-assited treatment in Switzerland--current results and future improvements]. Ther Umsch (2003) 0.75
[Estimating the age of start of drug abuse in cross-sectional surveys exemplified by the Swiss Health Survey]. Soz Praventivmed (1996) 0.75
[Social rehabilitation of addicts (author's transl)]. Ther Umsch (1979) 0.75
[The schizophrenic as ambulatory patient]. Schweiz Arch Neurol Psychiatr (1985) 0.75
[Problems of rehabilitation of chronic schizophrenic psychoses]. Schweiz Arch Neurol Neurochir Psychiatr (1973) 0.75
[Drugs and their way of application in juvenile drug abuse. A dimension-analytical study of consumption habits]. Soz Praventivmed (1976) 0.75
[Function of psychiatric social service]. Z Krankenpfl (1970) 0.75
Determination of third-year student exposure to and participation in learning objectives. Acad Med (1998) 0.75
[Methadone treatment of heroin addiction in family practice. Risks and guidelines]. Schweiz Rundsch Med Prax (1984) 0.75
[Pilot study on prescription of benzodiazepines in Switzerland: does cognitive availability of legal rules affect medical prescribing behavior]. Gesundheitswesen (2004) 0.75
[Construction and validation of an indicator for alcohol problems in the Swiss Health Survey]. Soz Praventivmed (1996) 0.75
[The residential structure as a therapeutic instrument]. Psychiatr Prax (1984) 0.75
[Social targets of psychiatry]. Schweiz Arch Neurol Neurochir Psychiatr (1978) 0.75
Compulsory measures in psychiatric emergencies. Schweiz Arch Neurol Psychiatr (1986) 0.75
[Psychotics and psychotic treatment in ambulatory psychiatry today]. Schweiz Arch Neurol Neurochir Psychiatr (1982) 0.75
[Sociology and schizophrenia]. Schweiz Arch Neurol Neurochir Psychiatr (1984) 0.75
Schizophrenia-like Rorschach results among the consanguine relatives of schizophrenics. Schizophr Bull (1985) 0.75
[Mental disorders in women. An epidemiologic-social psychiatric view]. Schweiz Arch Neurol Neurochir Psychiatr (1975) 0.75
[Sheltered living and sheltered work for psychiatric patients in an urban region (Zurich, Switzerland) - experiences and trends (author's transl)]. Psychiatr Prax (1980) 0.75